STOCK TITAN

Exelixis (EXEL) EVP sells 43,451 shares, holding 594,741 after

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

EXELIXIS, INC. executive Dana Aftab, EVP of Research and Development, reported an open-market sale of Common Stock. On May 26, 2026, Aftab sold 43,451 shares of Exelixis common stock at $50.35 per share.

After this transaction, Aftab directly holds 594,741 shares of common stock. In addition, a separate entry shows 5,835 shares held indirectly through the Exelixis 401(k) Plan. Footnotes also note 405,966 shares that may be issued upon vesting of restricted stock units and performance-based restricted stock units, each representing the right to receive one share of common stock.

Positive

  • None.

Negative

  • None.
Insider Aftab Dana
Role EVP, Research and Development
Sold 43,451 shs ($2.19M)
Type Security Shares Price Value
Sale Common Stock 43,451 $50.35 $2.19M
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 594,741 shares (Direct, null); Common Stock — 5,835 shares (Indirect, By 401(k))
Footnotes (1)
  1. Includes 405,966 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"), and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 26, 2026.
Shares sold 43,451 shares Open-market sale of Common Stock on May 26, 2026
Sale price $50.35 per share Price for 43,451 shares of Common Stock sold
Direct holdings after sale 594,741 shares Common Stock directly owned following the transaction
401(k) plan holdings 5,835 shares Shares of Common Stock held indirectly via 401(k) Plan
Unvested RSUs and PSUs 405,966 shares Shares potentially issuable upon vesting of RSUs and One-Time Award PSUs
Net shares sold 43,451 shares Net buy/sell shares reported as a net-sell in summary
restricted stock units ("RSUs") financial
"Includes 405,966 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs")"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
performance-based restricted stock unit award financial
"and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs")"
A performance-based restricted stock unit award is a promise to give company shares to an employee or executive only if the business hits specific targets over a set period. Think of it as a conditional prize that vests like a savings plan: if agreed goals (such as revenue, profit, or stock performance) are met, the recipient receives the shares; if not, they get nothing. Investors pay attention because these awards align management incentives with company results and can affect share count, future earnings and executive behavior.
One-Time Award PSUs financial
"and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs")"
401(k) Plan financial
"Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 26, 2026."
A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Aftab Dana

(Last)(First)(Middle)
C/O EXELIXIS, INC.
1851 HARBOR BAY PARKWAY

(Street)
ALAMEDA CALIFORNIA 94502

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
EXELIXIS, INC. [ EXEL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, Research and Development
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/26/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/26/2026S43,451D$50.35594,741(1)D
Common Stock5,835(2)IBy 401(k)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Includes 405,966 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"), and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
2. Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 26, 2026.
Remarks:
/s/ Nina Ayer, Attorney in Fact05/28/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

How many EXELIXIS (EXEL) shares did EVP Dana Aftab sell?

Dana Aftab sold 43,451 shares of Exelixis common stock. The transaction was reported as an open-market sale and is classified as a non-derivative transaction in Common Stock on May 26, 2026.

What was the sale price for Dana Aftab’s EXEL shares?

The reported sale price was $50.35 per share of Exelixis common stock. This price applies to the 43,451 shares sold in the open-market transaction dated May 26, 2026.

How many EXELIXIS shares does Dana Aftab hold after the sale?

Following the sale, Dana Aftab directly holds 594,741 shares of Exelixis common stock. This direct holding figure is reported as the total shares owned after the non-derivative transaction.

Does Dana Aftab have indirect EXELIXIS holdings through a 401(k) plan?

Yes. The filing reports 5,835 shares of Exelixis common stock held indirectly via the Exelixis, Inc. 401(k) Plan, based on a plan statement dated May 26, 2026.

What restricted stock units (RSUs) and PSUs does Dana Aftab hold in EXELIXIS?

Footnotes indicate 405,966 shares of Exelixis common stock may be issued to Aftab upon vesting of RSUs and a performance-based RSU award. Each RSU and PSU represents the right to receive one share of common stock.

What is Dana Aftab’s role at EXELIXIS (EXEL)?

Dana Aftab serves as Executive Vice President, Research and Development at Exelixis, Inc. This senior leadership role is specified in the insider ownership and transaction disclosure.